Villepinte (France), February 25, 2021 (8:00 a.m. CET) - Guerbet (FR0000032526 GBT), a global leader in medical imaging, has announced the launch of OptiProtect™ 3S, a new range of technical services for its injection solutions. OptiProtect™ 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
Guerbet's teams of certified, factory trained local experts are dedicated to OptiProtect™ 3S to ensure the continuity of operations in imaging centers. The engineers and selected service providers receive training at Guerbet's centers of excellence in Cincinnati (USA) and Lyon (France), and their certifications are renewed every 24 months.
OptiProtect™ 3S (Smart Service Solutions) is a suite of technical services and support designed for all Guerbet injectors, with three offers ranging from preventive maintenance to full equipment protection including service continuity. Guerbet also offers a range of optional services for customized support (https://www.guerbet.com/products-solutions/service-support/optiprotect-3s/).
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Philippe Godet, Sales Operations Leader & Head Technical Services at Guerbet, says: "OptiProtect™ 3S is an essential part of our UNIK interconnected solutions and plays a major role in Guerbet's long-term partnership with imaging centers. OptiProtect™ Smart Service Solutions ensure that the injectors are maintained at their highest level by their manufacturer, while also avoiding unforeseen expenses and benefiting from the daily support of local experts".
Guerbet is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. A pioneer since more than 90 years in the field of contrast media with over 2,600 people globally, Guerbet is continuously innovating with 9% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B - mid caps) and generated €712 million in revenue in 2020. For more information about Guerbet, please visit www.guerbet.com.